Yidian Zhao

机构：Anyang Tumor Hospital

发表论文 33 篇 · 总被引 242 次 · h-index 9

代表论文

• High-Dose Versus Standard-Dose Intensity-Modulated Radiotherapy With Concurrent Paclitaxel Plus Carboplatin for Patients With Thoracic Esophageal Squamous Cell Carcinoma: A Randomized, Multicenter, Open-Label, Phase 3 Superiority Trial (2022 · International Journal of Radiation Oncology*Biology*Physics · 被引 42)
• Clinical practice and outcome of radiotherapy for advanced esophageal squamous cell carcinoma between 2002 and 2018 in China: the multi-center 3JECROG Survey (2021 · Acta Oncologica · 被引 30)
• Effectiveness of S-1–Based Chemoradiotherapy in Patients 70 Years and Older With Esophageal Squamous Cell Carcinoma (2023 · JAMA Network Open · 被引 28)
• Does chemoradiotherapy benefit elderly patients with esophageal squamous cell cancer? A propensity-score matched analysis on multicenter data (3JECROG R-03A) (2020 · BMC Cancer · 被引 21)
• S-1–Based Chemoradiotherapy Followed by Consolidation Chemotherapy With S-1 in Elderly Patients With Esophageal Squamous Cell Carcinoma: A Multicenter Phase II Trial (2020 · Frontiers in Oncology · 被引 20)
• Quality of life and survival outcomes of patients with inoperable esophageal squamous cell carcinoma after definitive radiation therapy: A multicenter retrospective observational study in China from 2015 to 2016 (2023 · Journal of the National Cancer Center · 被引 18)